Nirmidas Biotech
Pre-clinicalNirmidas Biotech was founded in September of 2013. The founding mission was to develop and commercialize the new innovations including tools and reagents for cutting edge life science research and clinical translations. We are a member of the Janssen Labs (JLABS) and QB3 programs, the Stanford StartX Med Program, and the MIT Industrial Liaison Program (MIT ILP). We are also a StartX Med COVID-19 Task Force Company since early 2020.
About
Nirmidas Biotech was founded in September of 2013. The founding mission was to develop and commercialize the new innovations including tools and reagents for cutting edge life science research and clinical translations. We are a member of the Janssen Labs (JLABS) and QB3 programs, the Stanford StartX Med Program, and the MIT Industrial Liaison Program (MIT ILP). We are also a StartX Med COVID-19 Task Force Company since early 2020.
Funding History
2Total raised: $15.3M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile